Paper2736216
An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancer.
Cooper EH and 4 others. Br J Cancer, 1989. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancer. Papers, record 2736216. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2736216
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Antigens, Tumor-Associated, Carbohydrate | Major topic |
| Biomarkers, Tumor | Major topic |
| Breast Neoplasms | Major topic |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Middle Aged | |
| Neoplasm Staging |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6127052 | Markers in breast and lung cancer. | Ann Clin Biochem | 1982 | https://conductscience.org/library/papers/6127052 | PubMed |
| 2 | 6349673 | Structure and function of the Ca antigen. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6349673 | PubMed |
| 3 | 6692267 | Biological markers for breast carcinoma. | Cancer | 1984 | https://conductscience.org/library/papers/6692267 | PubMed |
| 4 | 6206003 | Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. | Int J Cancer | 1984 | https://conductscience.org/library/papers/6206003 | PubMed |
| 5 | 2415385 | Monoclonal antibodies against antigens on breast cancer cells. | Experientia | 1985 | https://conductscience.org/library/papers/2415385 | PubMed |
| 6 | 2461250 | Follow-up of metastatic breast cancer patients with a mucin-like carcinoma-associated antigen: comparison to CA 15.3 and carcinoembryonic antigen. | Cancer Lett | 1988 | https://conductscience.org/library/papers/2461250 | PubMed |
| 7 | 3462353 | Evaluation of CA15/3 serum levels in breast cancer patients. | J Nucl Med Allied Sci | 1986 | https://conductscience.org/library/papers/3462353 | PubMed |
| 8 | 2428949 | Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. | J Clin Oncol | 1986 | https://conductscience.org/library/papers/2428949 | PubMed |
| 9 | 3475109 | Value of CA 15:3 in the follow-up of breast cancer patients. | Br J Cancer | 1987 | https://conductscience.org/library/papers/3475109 | PubMed |
| 10 | 2449238 | Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer. | Br J Cancer | 1987 | https://conductscience.org/library/papers/2449238 | PubMed |
| 11 | 3168211 | Monitoring breast cancer with CA 549. | Clin Chem | 1988 | https://conductscience.org/library/papers/3168211 | PubMed |
| 12 | 2424847 | Molecular expression of epitopes recognized by monoclonal antibodies HMFG-1 and HMFG-2 in human breast cancers: diversity, variability and relationship to prognostic factors. | Int J Cancer | 1986 | https://conductscience.org/library/papers/2424847 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39456554 | Salivary Transmembrane Mucins of the MUC1 Family (CA 15-3, CA 27.29, MCA) in Breast Cancer: The Effect of Human Epidermal Growth Factor Receptor 2 (HER2). | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39456554 | PubMed |
| 26294353 | MUC1 (CD227): a multi-tasked molecule. | Cell Mol Life Sci | 2015 | https://conductscience.org/library/papers/26294353 | PubMed |
| 17116247 | Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases. | BMC Cancer | 2006 | https://conductscience.org/library/papers/17116247 | PubMed |
| 8132827 | Simple method for comparing reliability of two serum tumour markers in breast carcinoma. | J Clin Pathol | 1994 | https://conductscience.org/library/papers/8132827 | PubMed |
| 7987981 | Treatment of disease-negative but mucin-like carcinoma-associated antigen-positive breast cancer patients with tamoxifen: preliminary results of a prospective controlled randomized trial. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/7987981 | PubMed |
| 7599049 | Potential for cost economies in guiding therapy in patients with metastatic breast cancer. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7599049 | PubMed |
| 2069833 | Use of mucin like cancer associated antigen (MCA) in the management of breast cancer. | Br J Cancer | 1991 | https://conductscience.org/library/papers/2069833 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2736216
GET https://conductscience.org/api/papers/v1/2736216/authors